Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes.

[1]  A. Benson,et al.  Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  E. Petre,et al.  Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy. , 2014, Clinical colorectal cancer.

[3]  Karen T. Brown,et al.  Margin Size is an Independent Predictor of Local Tumor Progression After Ablation of Colon Cancer Liver Metastases , 2013, CardioVascular and Interventional Radiology.

[4]  H. Amthauer,et al.  Matched-Pair Comparison of Radioembolization Plus Best Supportive Care Versus Best Supportive Care Alone for Chemotherapy Refractory Liver-Dominant Colorectal Metastases , 2012, CardioVascular and Interventional Radiology.

[5]  B. Ariff,et al.  The role of early 18F-FDG PET/CT in prediction of progression-free survival after 90Y radioembolization: comparison with RECIST and tumour density criteria , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  A. Haug,et al.  18F-FDG PET/CT Predicts Survival After Radioembolization of Hepatic Metastases from Breast Cancer , 2012, The Journal of Nuclear Medicine.

[7]  Matthew S. Johnson,et al.  Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. , 2012, Journal of vascular and interventional radiology : JVIR.

[8]  S. Alberts,et al.  Treatment advances in liver-limited metastatic colorectal cancer. , 2011, Clinical colorectal cancer.

[9]  M. Mulcahy,et al.  Radioembolization for primary and metastatic liver cancer. , 2011, Seminars in radiation oncology.

[10]  M. Gonen,et al.  CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. , 2011, Journal of vascular and interventional radiology : JVIR.

[11]  E. Van Cutsem,et al.  Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  F. Izzo,et al.  Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases , 2010, British Journal of Cancer.

[13]  K. Tatsch,et al.  Radiofrequency ablation after selective internal radiation therapy with Yttrium90 microspheres in metastatic liver disease-Is it feasible? , 2010, European journal of radiology.

[14]  Riccardo Lencioni,et al.  Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.

[15]  A. Benson,et al.  Accomplishments in 2008 in the management of curable metastatic colorectal cancer. , 2009, Gastrointestinal cancer research : GCR.

[16]  G. M. Briggs,et al.  Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  E. Cortesi,et al.  Selective Internal Radiation Therapy with SIR-Spheres for the Treatment of Unresectable Colorectal Hepatic Metastases , 2009, CardioVascular and Interventional Radiology.

[18]  A. Benson,et al.  Radioembolization of colorectal hepatic metastases using yttrium‐90 microspheres , 2009, Cancer.

[19]  R. Wahl,et al.  From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.

[20]  M. A. Bosch,et al.  Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis , 2009, European Radiology.

[21]  M. Reiser,et al.  Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. , 2008, Journal of vascular and interventional radiology : JVIR.

[22]  A. Benson,et al.  Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival. , 2008, Radiology.

[23]  B. Sangro,et al.  Liver disease induced by radioembolization of liver tumors , 2008, Cancer.

[24]  Yuman Fong,et al.  Actual 10-year survival after resection of colorectal liver metastases defines cure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  A. Benson,et al.  Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. , 2007, International journal of radiation oncology, biology, physics.

[26]  P. Gibbs,et al.  Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  T. Pawlik,et al.  Chemotherapy‐associated hepatotoxicity and surgery for colorectal liver metastases , 2007, The British journal of surgery.

[28]  N. Habib,et al.  Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: Value of FDG PET versus computed tomography , 2007, Nuclear medicine communications.

[29]  Kenneth G. Thurston,et al.  90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging. , 2005, Journal of vascular and interventional radiology : JVIR.

[30]  Ravi Murthy,et al.  Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[31]  E. Mitchell,et al.  Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer , 2005, Cancer investigation.

[32]  C. Nutting,et al.  Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. , 2004, International journal of radiation oncology, biology, physics.

[33]  G. van Hazel,et al.  Randomised phase 2 trial of SIR‐Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer , 2004, Journal of surgical oncology.

[34]  N. Hanna.  Radiofrequency ablation of primary and metastatic hepatic malignancies. , 2004, Clinical colorectal cancer.

[35]  S. Raman,et al.  Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[36]  V. Gebski,et al.  Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[37]  E F Halpern,et al.  Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. , 2001, Radiology.

[38]  M E Hammond,et al.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.

[39]  M. Burton,et al.  Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. , 2000, Physics in medicine and biology.

[40]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[41]  L H Blumgart,et al.  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. , 1999, The New England journal of medicine.

[42]  C. Ratto,et al.  Prognostic factors in colorectal cancer , 1998, Diseases of the colon and rectum.

[43]  N. Pavlakis,et al.  Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients. , 2012, Journal of vascular and interventional radiology : JVIR.

[44]  M. Roček,et al.  Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study , 2010, Annals of Surgical Oncology.

[45]  F. Miller,et al.  Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.

[46]  É. Vinet,et al.  Regional treatment of metastasis: surgery of colorectal liver metastases. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.